NeoFirst Life Launches Cancer Insurance Sales at Prudential Life Insurance
NeoFirst Life Insurance announces that Prudential Life Insurance Company of Japan will begin selling NeoFirst's cancer insurance product "Neo de Ganchiryou" from Monday, December 1, 2025.
This initiative is being implemented as part of the strategic business alliance between Prudential Financial and Dai-ichi Life Holdings announced on January 24, 2025. Through this business alliance leveraging the strengths of both companies, the partners aim to meet diversifying customer needs and further enhance the value they provide.
"Neo de Ganchiryou" is insurance designed to prepare for diversifying cancer treatments, offering coverage in the form of lump-sum benefits and monthly benefits for treatment received, which can be combined according to customers' preferences.
Moving forward, NeoFirst will continue working toward realizing its vision of "From life insurance to lifetime insurance: Insurance services that address even small life anxieties," as a partner that notices and addresses the small concerns its customers have and helps them achieve long and healthy lives.
Product Features
- Provides coverage for the three major cancer treatments (surgery, anti-cancer drug treatment, radiation therapy). Monthly benefits for treatment received and lump-sum benefits are available.
- Supports long-term treatment due to recurrence and metastasis. Also covers hormone therapy for recurrence prevention.
- Lump-sum benefits useful for income reduction situations. Free to use as needed. The "Cancer Diagnosis Benefit," which provides a lump-sum payment, can be received once a year as long as prescribed treatment continues.
- In addition to main contract coverage for non-insured medical care, fixed-amount type riders and actual-amount type optional coverage can be added.
- Fixed-amount type riders added to main contract benefits ⇒ Cancer Treatment Self-Pay Medical Care Additional Benefit Rider / Cancer Radiation Therapy and Anti-Cancer Drug Treatment Self-Pay Medical Care Additional Benefit Rider
- Actual-amount type optional coverage guaranteeing up to 100 million yen aggregate limit and 100 million yen per treatment period ⇒ Cancer Elective Medical Care Optional Coverage (for Whole Life Cancer Insurance)
- Supports costs beyond treatment expenses.
- "Carcinoma in situ" is covered at the same amount.
- No premiums required for the non-coverage period (3 months). No double payment of premiums occurs when reviewing your contract.
- Non-smokers receive lower premiums.
Norbert Gehrke
